Quantcast

Latest Diagnostic test Stories

2014-09-01 23:01:01

New research study “Early-Stage Minimally-Invasive Biomarkers in Alzheimer's Disease: A Comprehensive Analysis and Market Study of New Developments and Opportunities, 2014” worked out by Biopharm Reports is now available at MarketPublishers.com. London, UK (PRWEB) September 01, 2014 Currently, scientists continue to face fundamental challenges in developing more effective treatments for Alzheimer's disease (AD), which reflects their poor understanding of the disease....

2014-08-07 12:28:07

NUSSLOCH, Germany, August 7, 2014 /PRNewswire/ -- - Leica Biosystems announces a collaboration with Bristol-Myers Squibb to develop companion diagnostic tests in support of targeted therapeutics - Leica Biosystems will develop fully automated tissue-based companion diagnostic tests to run on the BOND(TM) automated advanced staining systems Leica Biosystems, today announced an agreement with Bristol-Myers Squibb Company (NYSE:...

2014-08-05 12:31:12

TUCSON, Ariz., Aug. 5, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announces a new agreement with Quintiles, Inc. to offer College of American Pathology (CAP)-standard companion diagnostic testing services in China for pharmaceutical and biotech companies conducting early phase clinical trials. This is great news for patients as China is one of the only countries in the world that requires all patient samples be tested in China,...

2014-07-30 08:32:03

Investment will support scale of global services, development of independent diagnostic tests, and deployment of future companion diagnostic products SAN DIEGO, July 30, 2014 /PRNewswire/ -- Epic Sciences, Inc. ("Epic"), a privately held biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the completion of a $30 million Series C Preferred Stock financing. The financing included new investors...

2014-07-15 23:14:13

North American Seminars provides pre-approved course that can be used for re-licensure for physical therapists and physical therapy assistants in California and Nevada. Examination and Treatment of the Hip Joint, a PT Online Continuing Education Course from Healthclick has been pre-approved for 10 hrs for PT & PTA's licensed in CA and NV. Franklin, TN (PRWEB) July 15, 2014 Examination and Treatment of the Hip Joint is an online physical therapy continuing education course...

2014-07-10 12:30:06

TUCSON, Ariz., July 10, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced it has entered into an agreement with Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA's biopharmaceutical division on the development and commercialization of a companion diagnostic (CDx) for an undisclosed target using Ventana's proprietary diagnostic assays. In alignment with...

2014-06-24 08:29:45

Future revisions to in-vitro diagnostics laws will offset the launch of new tests, in a market expected to soar to $1,295.1 million in 2018 LONDON, June 24, 2014 /PRNewswire/ -- With the growth in personalised medicine, there is an increased interest in developing companion diagnostics (CDx) tests or tests that match the right therapy to the patient. In fact, over the past few years, market participants have been entering pharmaceutical and diagnostic partnerships in a bid to develop...

2014-06-16 08:28:21

MADISON, N.J. and SAN DIEGO, June 16, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, and Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced an agreement under which Quest will offer national access to Sequenom Laboratories' MaterniT21(TM) PLUS laboratory-developed test (LDT). Using a maternal blood sample, the noninvasive prenatal test (NIPT)...

2014-05-26 23:01:02

RnRMarketResearch.com adds “MediPoint: Companion Diagnostic Tests in Oncology – Global Analysis and Market Forecasts” to its store. Order a purchased copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=176910. Dallas, Texas (PRWEB) May 26, 2014 The major feature of the companion diagnostic testing market is the current domination of tests for mutations important in the prognosis and diagnosis of non-small cell lung cancer (NSCLC), with the two market leaders being Roche...

2014-05-20 08:34:42

Actor Announces Investment in Crowdsourced Medical Diagnosis Platform SAN FRANCISCO, May 20, 2014 /PRNewswire/ -- CrowdMed, an online crowdsourced medical diagnosis platform that helps solve even the world's most difficult medical cases, today announced that actor Patrick Dempsey has made an investment in the company. Almost one in 10 Americans - and 350 million people globally - are affected by the approximately 7,000 different types of rare or difficult-to-diagnose medical...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related